(111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY-Reference-Cited by-同舟云学术

(111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

Published:1998-06 Issue:6 Volume:159 Page:2041-2047
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

KAHN DANIEL¹,WILLIAMS RICHARD D.¹,MANYAK MICHAEL J.¹,HASEMAN MICHAEL K.¹,SELDIN DAVID W.¹,LIBERTINO JOHN A.¹,MAGUIRE ROBERT T.¹,

Affiliation:

1. From the Veterans Affairs Medical Center, Nuclear Medicine Service and Departments of Radiology and Urology, University of Iowa, Iowa City, Iowa, Department of Urology, George Washington University Medical Center, Washington, D. C., Department of Nuclear Medicine, Sutter General Hospital, Sacramento, California, Departments of Nuclear Medicine and Urology, Lahey Hitchcock Medical Center, Burlington, Massachusetts, and CYTOGEN Corporation, Princeton, New Jersey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer;Mettlin;CA,1993

2. The value of serum prostate specific antigen determinations before and after radical prostatectomy;Lange;J. Urol.,1989

3. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate;Oesterling;J. Urol.,1991

4. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy;Frazier;J. Urol.,1993

5. Clinical assessment of (111) In-CYT-103 immunoscintigraphy in ovarian cancer;Surwit;Gynec. Oncol.,1993

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?;Pharmaceuticals;2024-04-16

2. Traditional and novel imaging modalities for advanced prostate cancer: A critical review;Urology Annals;2023

3. Advances in PSMA theranostics;Translational Oncology;2022-08

4. Tumor-Targeting Agents;Nuclear Medicine and Immunology;2021-11-25

5. Review of commonly used prostate specific PET tracers used in prostate cancer imaging in current clinical practice;Clinical Imaging;2021-11